Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.
MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23
There are two main goals to perform neoadjuvant systemic therapy for women with breast cancer. The first goal is to obtain a pathological complete response (PCA) and the second reason is because we want to perform a less aggressive surgery.
In this OncologyPRO educational video of the "How to" series, Sofia Braga explains how to use neoadjuvant therapies in Breast cancer patients according to risk factors and tumour type.
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.
